<DOC>
	<DOCNO>NCT01151813</DOCNO>
	<brief_summary>This Phase II within-subjects double-blind placebo-controlled human laboratory study . The purpose study determine efficacy varenicline ( Chantix ) reduce cue-induced cocaine alcohol craving .</brief_summary>
	<brief_title>Human Behavioral Pharmacology Laboratory ( HBPL ) Study Varenicline 's Impact Cocaine Alcohol Craving</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Subject male female 21 65 year age . 2 . The subject use cocaine , alcohol , cocaine alcohol least per month least past year , use cocaine , alcohol , cocaine alcohol within past 30 day . 3 . Live within commutable distance Treatment Research Center ( TRC ) Penn/VA Center Studies Addiction , University Pennsylvania . We define distance within service area Septa , within hour drive , distance patient Principal Investigator ( PI ) find acceptable . 4 . Understands sign inform consent . 1 . Meets DSMIV criterion current dependence substance nicotine , cocaine , alcohol marijuana . 2 . Subjects currently take antidepressant medication ( e.g. , SSRIs citalopram ) 3 . Patients diagnose screen clinical depression use HAMD rating scale present score &gt; 10 . 4 . Subjects diagnose anxiety diagnose use HAMA anxiety scale score &gt; 17 5 . Subjects meet current lifetime DSMIV criterion psychotic disorder ( e.g. , schizophrenia ) 6 . Requires treatment psychotropic medication ( e.g. , antidepressant , antipsychotic , benzodiazepine , mood stabilize medication ) . 7 . Subjects test positive urine drug screen illicit drug cocaine marijuana screening allow single retest . Those individual test positive amphetamine screening , give provide copy prescription , include safely discontinue amphetamine use duration study . Subjects need provide urine free illicit drug cocaine marijuana study onset randomize . Subjects test positive drug marijuana prior study session allow single retest chance reschedule session . If subject test positive drug marijuana retest , participation study terminate . 8 . Use investigational medication within past 30 day . 9 . Concomitant use one follow drug class drug : Antidepressant drug citalopram , fluoxetine ; antipsychotic drug haloperidol ; benzodiazepine anxiolytic medication ; Antihypertensive drug Reserpine , Verapamil ; Blood thinner Medications use treat respiratory diseases theophylline ; Trimethoprim ; Cimetidine ; Antiepileptic drug ( AEDs ) phenytoin valproic acid . 10 . Patients know hypersensitivity varenicline . 11 . Patients severe unstable serious medical illness seizure disorder , unstable cerebrovascular disease , bronchospastic disease , hyperthyroidism , diabetes mellitus . 12 . Patients known AIDS serious illness may require hospitalization study . 13 . Female subject pregnant , plan become pregnant , currently lactate , childbearing potential use acceptable method birth control ; acceptable method birth control would include : 1 . Barrier method ( diaphragm condom ) 2 . Intrauterine progesterone contraceptive system 3 . Levonorgesterel implant 4 . Medroxyprogesterone acetate contraceptive injection , 5 . Oral contraceptive . 14 . Patients impaired renal function , indicate correct creatinine clearance 60 ml/min determine modify Cockcroft equation ( CDC , 1986 ) . 15 . An unacceptable liver panel ( liver function test ; LFTs ) may indicative hepatic dysfunction . 16 . Clinical laboratory test ( e.g. , CBC , blood chemistry , urinalysis ) outside normal limit , determine PI . 17 . History significant heart disease dysfunction ( e.g. , arrhythmia require medication , Wolff Parkinson White Syndrome , angina pectoris , document history myocardial infarction , heart failure ) . 18 . Electrocardiography ( EKG ) indicative 1st degree heart block , sinus tachycardia , leftaxis deviation , nonspecific ST Twave change . 19 . History chest pain associate cocaine use prompt visit physician . 20 . Any medical psychological condition could jeopardize subject 's safe participation trial determine PI .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>